Trefoil Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
Dose Escalation TTHX1114 Ophthalmic Solution
Phase 1
Completed
- Conditions
- Corneal Epithelial Degeneration
- Interventions
- Drug: TTHX1114(NM141) Ophthalmic Solution
- First Posted Date
- 2023-03-15
- Last Posted Date
- 2023-04-18
- Lead Sponsor
- Trefoil Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT05769920
- Locations
- 🇺🇸
Trefoil Clinical Site #132, Cypress, California, United States
A Safety and Efficacy Trial of TTHX1114 in People With CED
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Trefoil Therapeutics, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT04812067
- Locations
- 🇺🇸
Trefoil Study Site, Washington, Missouri, United States
TTHX1114(NM141) in Combination With DWEK/DSO
Phase 2
Completed
- Conditions
- Fuchs' Endothelial DystrophyFuchs DystrophyFuchs
- Interventions
- Drug: TTHX1114(NM141)
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Trefoil Therapeutics, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT04676737
- Locations
- 🇺🇸
Vance Thompson Vision - Sioux Falls, Sioux Falls, South Dakota, United States
🇺🇸Trefoil Investigational Site 120, Cincinnati, Ohio, United States
🇺🇸North Bay Eye Associates, Petaluma, California, United States
A Phase 1/ Phase 2 Study of TTHX1114(NM141)
Phase 1
Completed
- Conditions
- Corneal Endothelial DystrophyFuchs Endothelial Corneal DystrophyPseudophakic Bullous KeratopathyEndothelial Dysfunction
- Interventions
- Other: Vehicle (placebo)Drug: TTHX1114(NM141)
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Trefoil Therapeutics, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04520321
- Locations
- 🇺🇸
Tauber Eye Center, Kansas City, Missouri, United States
🇺🇸Chicago Corneal Consultants, Hoffman Estates, Illinois, United States
🇺🇸North Bay Eye Associates, Inc., Petaluma, California, United States
© Copyright 2025. All Rights Reserved by MedPath